Conventional therapy

9/98–10/99Chemotherapy: AB/CM
2/99–10/99Chemotherapy: cytoxan, melphalan, decadron, zofran q 3weeks
6/1/01Chemotherapy: thalodimide, biaxin, decradron

From: Appendix E: Additional Cases Reviewed

Cover of Best-Case Series for the Use of Immuno-Augmentation Therapy and Naltrexone for the Treatment of Cancer
Best-Case Series for the Use of Immuno-Augmentation Therapy and Naltrexone for the Treatment of Cancer.
Evidence Reports/Technology Assessments, No. 78.
Coulter I, Hardy M, Shekelle P, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.